Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
grade B 10.03 2.14% 0.21
CVM closed up 2.14 percent on Friday, January 17, 2020, on 2.14 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CVM trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish 2.14%
New 52 Week Closing High Bullish 2.14%
Calm After Storm Range Contraction 10.22%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.
Medicine Cancer Medical Specialties Immunology Immunotherapy Immune System Rheumatoid Arthritis Vaccination Autoimmunity Transplantation Head And Neck Cancer Vaccine Allergies Treatment Of Head And Neck Cancer

Is CVM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.35
52 Week Low 2.37
Average Volume 606,335
200-Day Moving Average 7.38
50-Day Moving Average 8.11
20-Day Moving Average 8.88
10-Day Moving Average 8.82
Average True Range 0.65
ADX 29.83
+DI 39.52
-DI 14.14
Chandelier Exit (Long, 3 ATRs ) 8.40
Chandelier Exit (Short, 3 ATRs ) 9.31
Upper Bollinger Band 10.10
Lower Bollinger Band 7.67
Percent B (%b) 0.97
BandWidth 27.39
MACD Line 0.34
MACD Signal Line 0.23
MACD Histogram 0.1051
Fundamentals Value
Market Cap 93.61 Million
Num Shares 9.33 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -6.51
Price-to-Sales 102.40
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.23
Resistance 3 (R3) 11.20 10.78 11.03
Resistance 2 (R2) 10.78 10.47 10.79 10.96
Resistance 1 (R1) 10.40 10.28 10.59 10.43 10.90
Pivot Point 9.98 9.98 10.07 9.99 9.98
Support 1 (S1) 9.60 9.67 9.79 9.63 9.16
Support 2 (S2) 9.18 9.48 9.19 9.10
Support 3 (S3) 8.80 9.18 9.03
Support 4 (S4) 8.83